Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengfei Chen

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Cell Stem Cell|June 11, 2013
Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogrammingHe Zhang, Weiwei Jiao, Lin Sun, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Journal of Extracellular Vesicles|March 15, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Cell Stem Cell|June 11, 2013
Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogrammingHe Zhang, Weiwei Jiao, Lin Sun, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Journal of Extracellular Vesicles|March 15, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Pageof 9